NCT01613482 2026-03-16
TSARINE
Centre Oscar Lambret
Phase 3 Terminated
Clinical Trials
6 trialsNCT04784715 2026-02-20
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)
AstraZeneca
Phase 3 Active not recruiting
NCT02492711 2025-03-17
SOPHIA
MacroGenics
Phase 3 Completed
NCT03811418 2019-11-26
ATTILA
iOMEDICO AG
Phase 3 Withdrawn
NCT00876395 2018-12-19
BOLERO-1
Novartis
Phase 3 Completed
NCT00637325 2008-03-17
TOP
Regione Lombardia
Phase 3 Unknown